Diagnostics
New research in the area of diagnostics detailed
Published in Hepatitis Weekly, September 12th, 2005
Study 1: In situ hybridization can't detect hepatitis C RNA in all liver tissue samples.
"Fourteen hepatitis C virus (HCV) chronically infected patients were submitted to routine liver biopsy for histological evaluation. Liver samples were assayed to HCV-RNA by in situ hybridization (ISH), using digoxigenin labeled probe," researchers in Brazil report.
"HCV genotypes were found to be predominantly type I (71.4%), followed by genotype 3 (21.4%), and genotype 2 (7.2%). Alanine-aminotransferase levels were raised in 10 patients. The histopathological scores...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-09-12)
More Articles from Hepatitis Weekly
- Hemophilia Complications
Researchers analyze HCV and HIV in co-infected hemophiliacs - Hepatitis B Virus
Minipool nucleic acid testing effective against transfusion-transmitted HBV - Hepatitis B Virus
Novel immunostimulator proves a good weapon in fight against HBV - Hepatitis C Virus
Scientists develop viral culture system to help define antiviral strategies - Hepatitis C Virus Treatment
Caution required with systemic corticosteroids due to adverse effects on HCV - Acute Lymphoblastic Leukemia
Pediatric protocols yield better outcomes for young-adult ALL patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
